Live feed
Filing
SC 13D/A
SC 13D/A0001193125-22-043289·Arix Bioscience plc
Schedule 13D ownership disclosure
LogicBio Therapeutics, Inc.
Security class unavailable · CUSIP: 54142F102
Event date: 2022-02-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.6200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-043289
- Form type
- SC 13D/A
- Filer
- Arix Bioscience plc
- CIK
- CIK 1700449
- Filed
- Feb 15, 2022
- Reporting period
- Feb 02, 2022
- Description
- Schedule 13D beneficial ownership